Biopharmaceutical
Summary
Table of Contents
examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Actelion is a biopharmaceutical industry player focused on the discovery, development and commercialization of synthetic, small-molecule drugs to address high unmet medical needs. The industry player has subsidiaries in more than 25 countries including the US, Canada, Brazil, Australia, ...
More »Search ReportLinker
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
... Of going into even earlier- stage suffes. We also believe that gantenerumab has better properties than solanezumab, in that our antibody was deliberately made to bind and break down amyloid oligomers ...
... Has yet to agree on definitions for both terms, which can have implications for risk mitigation and raw materials consistency in biopharmaceutical production. The panel will also address questions ...
... Biomarin pharmaceutical inc. (Nasdaq: bmrn) is a multinational biopharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. Biomarin has ...
United States
Europe
World
Japan
Canada
Brazil
Australia
Switzerland
ref:plp2011
Reportlinker.com © Copyright 2013. All rights reserved.